{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:14:56Z","timestamp":1780582496641,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11886-020-01291-4","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T05:02:27Z","timestamp":1586840547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Outcomes in Patients with COVID-19 Infection Taking ACEI\/ARB"],"prefix":"10.1007","volume":"22","author":[{"given":"Juan Simon","family":"Rico-Mesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averi","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"1291_CR1","doi-asserted-by":"crossref","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. [published online ahead of print (February 24, 2020)]. JAMA. 2020.","DOI":"10.1001\/jama.2020.2648"},{"issue":"5","key":"1291_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jmv.25709","volume":"92","author":"Jia Liu","year":"2020","unstructured":"Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M., Lu M., Dittmer U., Yang D. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARSCoV, MERS-CoV, and 2019- nCoV. J Med Virol. 2020;92(5):491\u20134.","journal-title":"Journal of Medical Virology"},{"key":"1291_CR3","doi-asserted-by":"crossref","unstructured":"Sparks MA, Crowley SD, Gurley SB, Mirotsou M, Coffman TM. Classical renin- angiotensin system in kidney physiology. Compr Physiol. 2014;4(3):1201\u201328.","DOI":"10.1002\/cphy.c130040"},{"issue":"3","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"Thirumalaisamy P. Velavan","year":"2020","unstructured":"Velavan TP, Meyer CG. The COVID-19 epidemic. Tropical Med Int Health. 2020;25(3):278\u201380.","journal-title":"Tropical Medicine & International Health"},{"issue":"1","key":"1291_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.06.003","volume":"128","author":"Keiji Kuba","year":"2010","unstructured":"Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin- angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128(1):119\u201328.","journal-title":"Pharmacology & Therapeutics"},{"key":"1291_CR6","doi-asserted-by":"crossref","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. [published online ahead of print (February 24, 2020)]. Lancet Respir Med. 2020.","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"1291_CR7","doi-asserted-by":"crossref","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B, Li LJ, eng G, Yuen KY, Chen R, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Z NS. Clinical characteristics of coronavirus disease 2019 in China. [published online ahead of print (February 28, 2020)]. N Engl J Med. 2020.","DOI":"10.1101\/2020.02.06.20020974"},{"key":"1291_CR8","doi-asserted-by":"crossref","unstructured":"Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. [published online ahead of print (February 19, 2020)]. Allergy. 2020.","DOI":"10.1111\/all.14238"},{"key":"1291_CR9","unstructured":"Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY, He MA, Cheng LX, Huang K, Zeng QT. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. [published online ahead of print (March 2, 2020)]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(0):E004."},{"issue":"1","key":"1291_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","volume":"36","author":"Tariq Alhogbani","year":"2016","unstructured":"Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Ann Saudi Med. 2016;36(1):78\u201380.","journal-title":"Annals of Saudi Medicine"},{"issue":"10223","key":"1291_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"Chaolin Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"The Lancet"},{"issue":"4","key":"1291_CR12","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"Lei Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):PE21.","journal-title":"The Lancet Respiratory Medicine"},{"key":"1291_CR13","unstructured":"Nahum LH. The renin angiotensin-aldosterone system (RAAS) in normal man. Conn Med. 1965;29(10):710\u20131."},{"key":"1291_CR14","doi-asserted-by":"publisher","first-page":"m810","DOI":"10.1136\/bmj.m810","volume":"368","author":"J Watkins","year":"2020","unstructured":"Watkins J. Preventing a covid-19 pandemic. BMJ. 2020;368:m810.","journal-title":"BMJ."},{"issue":"20","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"Carlos M. Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensinconverting enzyme 2. Circulation. 2005;111(20):2605\u201310.","journal-title":"Circulation"},{"key":"1291_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","volume":"125","author":"Xiao C. Li","year":"2017","unstructured":"Li XC, Zhang J, Zhuo JL. The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. Pharmacol Res. 2017;125(Pt A):21\u201338.","journal-title":"Pharmacological Research"},{"key":"1291_CR17","unstructured":"Sun ML, Yang JM, Sun YP, Su GH. Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(3):219\u201322."},{"issue":"1","key":"1291_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpu086","volume":"28","author":"M. Furuhashi","year":"2014","unstructured":"Furuhashi M, Moniwa N, Mita T, Fuseya T, Ishimura S, Ohno K, Shibata S., Tanaka M., Watanabe Y, Akasaka H, Ohnishi H, Yoshida H, Takizawa H, Saitoh S, Ura N, Shimamoto K, Miura T. Urinary angiotensinconverting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker. Am J Hypertens. 2015;28(1):15\u201321.","journal-title":"American Journal of Hypertension"},{"key":"1291_CR19","unstructured":"Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician [press release]. heart.org, March 17, 2020 2020."}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-020-01291-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T23:41:49Z","timestamp":1618357309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-020-01291-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-01291-4","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"14 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Rico-Mesa and Ms. White have nothing to disclose. Dr. Anderson has received honoraria from Novartis, Pfizer. He is a consultant for Edwards LifeSciences and received research support from Abbott.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This manuscript does not contain any studies with human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"31"}}